Formulation and Evaluation of Floating Tablets of Ranitidine Hydrochloride with Liquorice as Natural Ulcer Protective Agent

Poonam Sansarwal, Sunaina Sharma, Richa Ohri
{"title":"Formulation and Evaluation of Floating Tablets of Ranitidine Hydrochloride with Liquorice as Natural Ulcer Protective Agent","authors":"Poonam Sansarwal, Sunaina Sharma, Richa Ohri","doi":"10.25166/ijppr.2020.v17i01.04","DOIUrl":null,"url":null,"abstract":"The concurrent trend in pharmaceutical evolution accentuates the effectiveness of floating tablets over conventional dosage form. Furthermore, it facilitates site-specificity, controlled release and is irrespective of gastric emptying. The present study was carried out to enhance the bioavailability of Ranitidine HCl, a floating dosage form with controlled release. Ranitidine HCl has a narrow absorption window in the gastrointestinal tract; therefore its absorption was improved by modifying the dosage form. The action potential of a drug is synergized by combining it with a natural ulcer protective agent that is liquorice. The tablets were prepared by wet granulation method. The batches were formulated using a different ratio of HPMC K15 and Carbopol. It ensures the effectiveness of the formulation variable on drug release and buoyancy property of the delivery system. The prepared formulations show significant results obtained by pharmacopoeial quality control tests. In-vitro dissolution study was also performed to check whether the ratio of polymers was optimum for controlled release or not. The present study suggests that the Ranitidine HCl and liquorice together are well compatible with each other. However, the effectiveness of the drug combination partially depends upon the ratio of polymers. Poonam Sansarwal, Sunaina Sharma, Richa Ohri 1. Himalayan Institute of Pharmacy, Kala-amb, Himachal Pradesh, India-173030 2. LBR college of Pharmacy, Panchkula, Haryana, India-134109 Submission: 23 November 2019 Accepted: 29 November 2019 Published: 30 December 2019 www.ijppr.humanjournals.com Citation: Richa Ohri et al. Ijppr.Human, 2019; Vol. 17 (1): 38-59. 39 INTRODUCTION Most of the medicaments are administered by oral route due to high patient compliance. However, the ideal drug delivery system needs two basic components. Firstly, the drug should be delivered at a predetermined rate for a prolonged time, for the prevention of fluctuation in plasma concentration. Secondly, the drug should bind solely to its selective receptor. Unfortunately, available systems do not relay such kind of properties. Hence the time demands modification in conventional dosage form for the betterment of therapeutic efficacy and drug safety [1, 2]. Manufacturing sustained release or controlled release drug delivery systems can help overcome the above-mentioned drawbacks. For instance, the major risk factor is decreased bioavailability due to the narrow absorption window. So far several new approaches such as bioadhesive, floating, swelling-activated drug delivery systems were made to lengthen the Gastric Retention Time (GRT)[3]. The existing trend in pharmaceutical evolution accentuates the effectiveness of floating tablets over conventional dosage form. On inference, it facilitates site-specificity, controlled release and is irrespective of gastric emptying[4, 5].Floating tablet tending to keep afloat for several hours. The buoyancy of tablets is achieved by gas generating agents that liberates carbon dioxide when came in contact with gastric fluid. Besides this, acidic pH assists entrapment of released CO2 in hydrocolloid gel that maintains extended floatation over long duration. There may be uncertain emptying of the floating system by settling in the stomach due to initial high density which goes down with time. on this emphasis floating system require an adequate amount of gastric fluid for tablet buoyancy[6]. The present study deals with the development of floating tablets of Ranitidine HCl in combination with natural ulcer protective agent that is liquorice. Ranitidine HCl abates acid secretion in the stomach by blocking histamine receptor H2. Liquorice is found to be effective in the treatment of gastric ulcers due to the antiulcer and anti-inflammatory properties of glycyrrhetinic acid[7, 8]. Liquorice elevates prostaglandin concentration in the digestive system that assists mucous secretion. Also, the antipepsin effect of liquorice perpetuates the life span of surface cells in the stomach[9]. www.ijppr.humanjournals.com Citation: Richa Ohri et al. Ijppr.Human, 2019; Vol. 17 (1): 38-59. 40 MATERIALS AND METHODS: MATERIALS: Ranitidine HCl(received as a gift sample from ZEE Labs Paonta Sahib, H.P ), Liquorice(extracted received as a gift sample from Konark herbal and health care, Kala Amb, H.P), Citric acid, Sodium bicarbonate, Carbopol, HPMC K15, Talc, Magnesium stearate, Ethanol, Hydrochloric acid, Sodium hydroxide, Potassium hydrogen diphosphate (SD fine chemicals). METHODS Construction of Calibration Curve: Preparation of simulated gastric fluid (SGF)[10] 2 g of sodium chloride was dissolved in 500 ml deionized water, followed by adding 7 ml of concentrated HCl and final volume made up to 1000 ml with water. The pH of the solution was adjusted to 1.2 with 0.1N HCl. Preparation of sample solutions of Ranitidine HCl The primary stock solution was prepared by dissolving 112 mg of pure Ranitidine HCl equivalent to 100 mg in 100ml SGF pH 1.2 to get a concentration of 1mg/ml. Secondary stock solution 5ml was pipetted out from the primary stock solution and transferred into 50 ml volumetric flask, the final volume was made up to 50 ml using SGF pH 1.2 Further sample solution of concentration 20 μg/ml, 40 μg/ml, 60 μg/ml, 80 μg/ml, 100 μg/ml were prepared from secondary stock solution. The absorbance was measured at 314 nm by UV spectrophotometer (Labindia Analytical) using SGF pH 1.2 as a blank solution. The calibration curve was plotted against concentration (x-axis) and absorbance (y-axis). Compatibility studies: Were performed by FT-IR of drug liquorice and polymers, and then interpretation was done to check compatibility. www.ijppr.humanjournals.com Citation: Richa Ohri et al. Ijppr.Human, 2019; Vol. 17 (1): 38-59. 41 Formulation of tablet by wet granulation method: Accurate quantity of Ranitidine HCl, liquorice were weighed and separately passed through a sieve of mesh size 40#, then mixed well. After those polymers i.e. HPMC K15 and Carbopol were mixed in required quantity to the mixture of drugs. Then added the sodium bicarbonate and citric acid in the mixture and mix well, these act as effervescent agents that maintain the floating properties of tablets. Wet mass of mixture was made with the help of 95% ethanol (granulating agent) and wet screening was done through a sieve with mesh aperture 10#. Drying of granules was done in a hot air oven at 40°C using a tray drying technique. Dry granules are sifted through a sieve with mesh aperture 40#, and about 15 % of the fine is allowed to remain in the granules. Finally, the dried granules are blended along with magnesium stearate and talc in an octagonal blender. Then the blend was compressed using a caimach compression machine. Table No. 1: Composition of one tablet for different batches Batch code Composition (Qty in mg) F1 F2 F3 F4 F5 Ranitidine HCl 168 168 168 168 168 Liquorice 50 50 50 50 HPMC K15 25 50 50 50 10 Carbopol 50 25 50 10 50 Citric acid 10 10 10 10 10 Sodium bicarbonate 50 60 70 80 90 Talc 5 5 5 5 5 Magnesium stearate 7 7 7 7 7 Pre-compression evaluation:[11, 12] 1. Bulk density and tapped density 2. Angle of repose 3. Compressibility index 4. Hausner’s ratio www.ijppr.humanjournals.com Citation: Richa Ohri et al. Ijppr.Human, 2019; Vol. 17 (1): 38-59. 42 Bulk density: 20 gm of granules were weighed and poured in measuring cylinder, bulk volume was measured. Bulk density was calculated using the formula: Bulk density = (mass of granules/bulk volume) x100 Tapped density: The measuring cylinder was tapped to get constant volume, followed by calculating tapped density using the expression: Tapped density= (mass of granules/tapped volume of granules) x100 The angle of repose (): a heap of the blend was formed using a funnel, followed by measuring height and radius of it. tan  = h/r  = tan (h/r) Where  = angle of repose h = height of heap of blend r = radius of a heap of blend Compressibility index & Hausner’s ratio: were determined by substituting the value of bulk density and tapped density in the formula: Compressibility index = (Tapped density-bulk density/Tapped density) x100 Hausner’s ratio= Tapped density/bulk density Evaluation of tablets: The prepared tablets were evaluated based on following parameters: www.ijppr.humanjournals.com Citation: Richa Ohri et al. Ijppr.Human, 2019; Vol. 17 (1): 38-59. 43 Physicochemical evaluation of floating tablets [13-15] Weight variation Twenty tablets were taken from the lot and their weight was measured followed by average weight. Then deviations from the average weight were calculated and compared with an IP 2014 limit of weight variation. Diameter and thickness: They were measured with the help of Vernier calliper. Friability: Roche friabilator was used to determine the friability. 20 tablets were selected and weighed (Winitial) and transferred to the friabilator. The friabilator was rotated at 25 rpm for 4 minutes. Then final weights of tablets were observed i.e. Wfinal. Percentage of friability was calculated using an expression: % Friability = (Winitial -Wfinal / Winitial) × 100 Hardness: Monsanto hardness tester was used to determine the hardness of tablets (Kg/cm). Swelling index: It was determined by keeping tablets in simulated gastric fluid. The swollen weight of tablets was observed at different time intervals. Then the swelling index was calculated using the formula: Swelling index= (wet weight-dry weight/dry weight) X100 In-vitro buoyancy study: Floating lag time and total floating time was evaluated for all batches of Ranitidine HCl. To determine floating lag time a tablet was selected randomly from each batch and kept in 100 ml beaker containing simulated gastric fluid (pH 1.2). Floating lag time was the time taken by each tablet to rise and float on the surface of a fluid. www.ijppr.humanjournals.com Citation: Richa Ohri et al. Ijppr.Human, 2019; Vol. 17 (1): 38-59. 44 The dissolution apparatus USP type I","PeriodicalId":92533,"journal":{"name":"International journal of pharmacy and pharmaceutical research","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of pharmacy and pharmaceutical research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25166/ijppr.2020.v17i01.04","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The concurrent trend in pharmaceutical evolution accentuates the effectiveness of floating tablets over conventional dosage form. Furthermore, it facilitates site-specificity, controlled release and is irrespective of gastric emptying. The present study was carried out to enhance the bioavailability of Ranitidine HCl, a floating dosage form with controlled release. Ranitidine HCl has a narrow absorption window in the gastrointestinal tract; therefore its absorption was improved by modifying the dosage form. The action potential of a drug is synergized by combining it with a natural ulcer protective agent that is liquorice. The tablets were prepared by wet granulation method. The batches were formulated using a different ratio of HPMC K15 and Carbopol. It ensures the effectiveness of the formulation variable on drug release and buoyancy property of the delivery system. The prepared formulations show significant results obtained by pharmacopoeial quality control tests. In-vitro dissolution study was also performed to check whether the ratio of polymers was optimum for controlled release or not. The present study suggests that the Ranitidine HCl and liquorice together are well compatible with each other. However, the effectiveness of the drug combination partially depends upon the ratio of polymers. Poonam Sansarwal, Sunaina Sharma, Richa Ohri 1. Himalayan Institute of Pharmacy, Kala-amb, Himachal Pradesh, India-173030 2. LBR college of Pharmacy, Panchkula, Haryana, India-134109 Submission: 23 November 2019 Accepted: 29 November 2019 Published: 30 December 2019 www.ijppr.humanjournals.com Citation: Richa Ohri et al. Ijppr.Human, 2019; Vol. 17 (1): 38-59. 39 INTRODUCTION Most of the medicaments are administered by oral route due to high patient compliance. However, the ideal drug delivery system needs two basic components. Firstly, the drug should be delivered at a predetermined rate for a prolonged time, for the prevention of fluctuation in plasma concentration. Secondly, the drug should bind solely to its selective receptor. Unfortunately, available systems do not relay such kind of properties. Hence the time demands modification in conventional dosage form for the betterment of therapeutic efficacy and drug safety [1, 2]. Manufacturing sustained release or controlled release drug delivery systems can help overcome the above-mentioned drawbacks. For instance, the major risk factor is decreased bioavailability due to the narrow absorption window. So far several new approaches such as bioadhesive, floating, swelling-activated drug delivery systems were made to lengthen the Gastric Retention Time (GRT)[3]. The existing trend in pharmaceutical evolution accentuates the effectiveness of floating tablets over conventional dosage form. On inference, it facilitates site-specificity, controlled release and is irrespective of gastric emptying[4, 5].Floating tablet tending to keep afloat for several hours. The buoyancy of tablets is achieved by gas generating agents that liberates carbon dioxide when came in contact with gastric fluid. Besides this, acidic pH assists entrapment of released CO2 in hydrocolloid gel that maintains extended floatation over long duration. There may be uncertain emptying of the floating system by settling in the stomach due to initial high density which goes down with time. on this emphasis floating system require an adequate amount of gastric fluid for tablet buoyancy[6]. The present study deals with the development of floating tablets of Ranitidine HCl in combination with natural ulcer protective agent that is liquorice. Ranitidine HCl abates acid secretion in the stomach by blocking histamine receptor H2. Liquorice is found to be effective in the treatment of gastric ulcers due to the antiulcer and anti-inflammatory properties of glycyrrhetinic acid[7, 8]. Liquorice elevates prostaglandin concentration in the digestive system that assists mucous secretion. Also, the antipepsin effect of liquorice perpetuates the life span of surface cells in the stomach[9]. www.ijppr.humanjournals.com Citation: Richa Ohri et al. Ijppr.Human, 2019; Vol. 17 (1): 38-59. 40 MATERIALS AND METHODS: MATERIALS: Ranitidine HCl(received as a gift sample from ZEE Labs Paonta Sahib, H.P ), Liquorice(extracted received as a gift sample from Konark herbal and health care, Kala Amb, H.P), Citric acid, Sodium bicarbonate, Carbopol, HPMC K15, Talc, Magnesium stearate, Ethanol, Hydrochloric acid, Sodium hydroxide, Potassium hydrogen diphosphate (SD fine chemicals). METHODS Construction of Calibration Curve: Preparation of simulated gastric fluid (SGF)[10] 2 g of sodium chloride was dissolved in 500 ml deionized water, followed by adding 7 ml of concentrated HCl and final volume made up to 1000 ml with water. The pH of the solution was adjusted to 1.2 with 0.1N HCl. Preparation of sample solutions of Ranitidine HCl The primary stock solution was prepared by dissolving 112 mg of pure Ranitidine HCl equivalent to 100 mg in 100ml SGF pH 1.2 to get a concentration of 1mg/ml. Secondary stock solution 5ml was pipetted out from the primary stock solution and transferred into 50 ml volumetric flask, the final volume was made up to 50 ml using SGF pH 1.2 Further sample solution of concentration 20 μg/ml, 40 μg/ml, 60 μg/ml, 80 μg/ml, 100 μg/ml were prepared from secondary stock solution. The absorbance was measured at 314 nm by UV spectrophotometer (Labindia Analytical) using SGF pH 1.2 as a blank solution. The calibration curve was plotted against concentration (x-axis) and absorbance (y-axis). Compatibility studies: Were performed by FT-IR of drug liquorice and polymers, and then interpretation was done to check compatibility. www.ijppr.humanjournals.com Citation: Richa Ohri et al. Ijppr.Human, 2019; Vol. 17 (1): 38-59. 41 Formulation of tablet by wet granulation method: Accurate quantity of Ranitidine HCl, liquorice were weighed and separately passed through a sieve of mesh size 40#, then mixed well. After those polymers i.e. HPMC K15 and Carbopol were mixed in required quantity to the mixture of drugs. Then added the sodium bicarbonate and citric acid in the mixture and mix well, these act as effervescent agents that maintain the floating properties of tablets. Wet mass of mixture was made with the help of 95% ethanol (granulating agent) and wet screening was done through a sieve with mesh aperture 10#. Drying of granules was done in a hot air oven at 40°C using a tray drying technique. Dry granules are sifted through a sieve with mesh aperture 40#, and about 15 % of the fine is allowed to remain in the granules. Finally, the dried granules are blended along with magnesium stearate and talc in an octagonal blender. Then the blend was compressed using a caimach compression machine. Table No. 1: Composition of one tablet for different batches Batch code Composition (Qty in mg) F1 F2 F3 F4 F5 Ranitidine HCl 168 168 168 168 168 Liquorice 50 50 50 50 HPMC K15 25 50 50 50 10 Carbopol 50 25 50 10 50 Citric acid 10 10 10 10 10 Sodium bicarbonate 50 60 70 80 90 Talc 5 5 5 5 5 Magnesium stearate 7 7 7 7 7 Pre-compression evaluation:[11, 12] 1. Bulk density and tapped density 2. Angle of repose 3. Compressibility index 4. Hausner’s ratio www.ijppr.humanjournals.com Citation: Richa Ohri et al. Ijppr.Human, 2019; Vol. 17 (1): 38-59. 42 Bulk density: 20 gm of granules were weighed and poured in measuring cylinder, bulk volume was measured. Bulk density was calculated using the formula: Bulk density = (mass of granules/bulk volume) x100 Tapped density: The measuring cylinder was tapped to get constant volume, followed by calculating tapped density using the expression: Tapped density= (mass of granules/tapped volume of granules) x100 The angle of repose (): a heap of the blend was formed using a funnel, followed by measuring height and radius of it. tan  = h/r  = tan (h/r) Where  = angle of repose h = height of heap of blend r = radius of a heap of blend Compressibility index & Hausner’s ratio: were determined by substituting the value of bulk density and tapped density in the formula: Compressibility index = (Tapped density-bulk density/Tapped density) x100 Hausner’s ratio= Tapped density/bulk density Evaluation of tablets: The prepared tablets were evaluated based on following parameters: www.ijppr.humanjournals.com Citation: Richa Ohri et al. Ijppr.Human, 2019; Vol. 17 (1): 38-59. 43 Physicochemical evaluation of floating tablets [13-15] Weight variation Twenty tablets were taken from the lot and their weight was measured followed by average weight. Then deviations from the average weight were calculated and compared with an IP 2014 limit of weight variation. Diameter and thickness: They were measured with the help of Vernier calliper. Friability: Roche friabilator was used to determine the friability. 20 tablets were selected and weighed (Winitial) and transferred to the friabilator. The friabilator was rotated at 25 rpm for 4 minutes. Then final weights of tablets were observed i.e. Wfinal. Percentage of friability was calculated using an expression: % Friability = (Winitial -Wfinal / Winitial) × 100 Hardness: Monsanto hardness tester was used to determine the hardness of tablets (Kg/cm). Swelling index: It was determined by keeping tablets in simulated gastric fluid. The swollen weight of tablets was observed at different time intervals. Then the swelling index was calculated using the formula: Swelling index= (wet weight-dry weight/dry weight) X100 In-vitro buoyancy study: Floating lag time and total floating time was evaluated for all batches of Ranitidine HCl. To determine floating lag time a tablet was selected randomly from each batch and kept in 100 ml beaker containing simulated gastric fluid (pH 1.2). Floating lag time was the time taken by each tablet to rise and float on the surface of a fluid. www.ijppr.humanjournals.com Citation: Richa Ohri et al. Ijppr.Human, 2019; Vol. 17 (1): 38-59. 44 The dissolution apparatus USP type I
甘草作为天然溃疡保护剂的盐酸雷尼替丁漂浮片的处方及评价
盐酸雷尼替丁样品溶液的制备主要储备溶液是通过将相当于100 mg的112 mg纯盐酸雷尼替定溶解在100 ml SGF pH 1.2中以获得1mg/ml的浓度来制备的。从一次储备溶液中吸取5ml二次储备溶液,并转移到50ml容量瓶中,使用SGF pH 1.2将最终体积调至50ml。从二次储备液中制备浓度为20μg/ml、40μg/ml、60μg/ml、80μg/ml、100μg/ml的样品溶液。使用SGF pH 1.2作为空白溶液,通过UV分光光度计(Labindia Analytical)在314nm处测量吸光度。根据浓度(x轴)和吸光度(y轴)绘制校准曲线。相容性研究:采用傅立叶变换红外光谱法对药物甘草和聚合物进行了研究,并对其相容性进行了解释。www.ijppr.humanjournals.com引文:Richa Ohri等人ijppr。人类,2019;第17卷(1):38-59。41湿法制粒法制备片剂:称量准确量的盐酸雷尼替丁、甘草,分别通过40#目筛,然后充分混合。在将这些聚合物即HPMC K15和Carbopol以所需量混合到药物混合物中之后。然后在混合物中加入碳酸氢钠和柠檬酸并充分混合,它们作为泡腾剂保持片剂的漂浮特性。在95%乙醇(造粒剂)的帮助下制备湿质量的混合物,并通过孔径为10#的筛网进行湿筛。颗粒的干燥在40°C的热风炉中使用托盘干燥技术进行。将干颗粒通过具有40#筛孔的筛网进行筛选,并且允许约15%的细粒保留在颗粒中。最后,将干燥的颗粒与硬脂酸镁和滑石在八角形搅拌器中混合。然后使用caimach压缩机对混合物进行压缩。表1:不同批次一片片剂的成分批次代码成分(数量,mg)F1 F2 F3 F4 F5雷尼替丁HCl 168 168 168 168甘草50 50 50 50 HPMC K15 25 50 50 10 Carbopol 50 50 50柠檬酸10 10 10 10碳酸氢钠50 60 70 80 90滑石5 5 5 5 55 5硬脂酸镁7 7 7 7 8 7 7 7压缩前评估:[11,12]1。堆积密度和振实密度2。休止角3。压缩指数4。Hausner比率www.ijppr.humanjournals.com引用:Richa Ohri等人ijppr。人类,2019;第17卷(1):38-59。42堆积密度:称量20克颗粒并倒入量筒中,测量堆积体积。堆积密度的计算公式为:堆积密度=(颗粒质量/堆积体积)x100敲击密度:敲击量筒以获得恒定体积,然后使用表达式计算敲击密度:轻敲密度=(粒子质量/颗粒敲击体积)x100.休止角(): 使用漏斗形成一堆混合物,然后测量混合物的高度和半径 = h/r = tan(h/r)其中 = 休止角h=混合物堆高度r=混合物堆半径压缩指数和豪斯纳比:通过将堆积密度和振实密度代入公式来确定:压缩指数=(振实密度-堆积密度/振实密度)x100豪斯纳比=振实密度/堆积密度片剂评价:制备的片剂基于以下参数:www.ijppr.humanjournals.com引用:Richa Ohri等人ijppr。人类,2019;第17卷(1):38-59。43漂浮片剂的理化评价[13-15]重量变化从批次中取出20片,测量其重量,然后测量平均重量。然后计算与平均体重的偏差,并将其与IP 2014的体重变化限值进行比较。直径和厚度:使用游标卡尺测量。脆性:采用罗氏脆性测定仪测定脆性。选择20片片剂并称重(Winitial),并转移到friabilator中。将脆性分子筛以25rpm旋转4分钟。然后观察片剂的最终重量,即Wfinal。使用以下表达式计算脆性百分比:%脆性=(Winitial-Wfinal/Winitial)×100硬度:使用孟山都硬度计测定片剂的硬度(Kg/cm)。溶胀指数:将片剂置于模拟胃液中测定。在不同的时间间隔观察片剂的溶胀重量。然后使用以下公式计算溶胀指数:溶胀指数=(湿重干重/干重)X100体外浮力研究:评估所有批次盐酸雷尼替丁的漂浮滞后时间和总漂浮时间。为了确定漂浮滞后时间,从每批中随机选择一片片剂,并将其保存在含有模拟胃液(pH 1.2)的100ml烧杯中。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信